Cleveland Clinic International IV Robotics Summit.

Autor: Long J; Cleveland Clinic, Cleveland, OH, USA., Calabrese S; Cleveland Clinic, Cleveland, OH, USA., Al-Jedai A; Ministry of Health, Riyadh, Saudi Arabia., Boyd A; Cleveland Clinic, Cleveland, OH, USA., Cotugno M; Brigham and Women's Hospital, Boston, MA, USA., Dorn M; Ohio State University Wexner Medical Center, Columbus, OH, USA., Fanikos J; Brigham and Women's Hospital, Boston, MA, USA., Freudiger MJ; Valley Children's Healthcare, Madera, CA, USA., Kraemer I; University Medical Center, Johannes Gutenberg-Universität Mainz, Mainz, Germany., Lopez-Cabezas C; Hospital Clinic of Barcelona, Barcelona, Spain., Smith A; Cleveland Clinic, Cleveland, OH, USA., de Stoppelaar FM; Cleveland Clinic London, London, United Kingdom., Usher J; Duke University Hospital, Durham, NC, USA., Yaniv AW; Cleveland Clinic, Cleveland, OH, USA., Knoer S; American Pharmacists Association, Washington, DC, USA.
Jazyk: angličtina
Zdroj: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2021 Apr 22; Vol. 78 (9), pp. 800-805.
DOI: 10.1093/ajhp/zxab050
Abstrakt: Purpose: The proceedings of an international summit on the current and desired future state of use of robotic systems to compound intravenous (IV) solutions are summarized.
Summary: The International IV Robotics Summit was held at the Cleveland Clinic main campus in Cleveland, OH, on April 29 and 30, 2019. The purpose of the summit was 2-fold: (1) to define the current state of robotic IV compounding and (2) to develop a guide for automation companies, pharmacy departments, and drug manufacturers to improve the technology and expand the use of IV robotics in health systems in the future. The first day of the summit included 45-minute presentations by each of the speakers. Each lecturer recounted a different hospital's experience implementing and using IV robotics. On day 2 of the summit, an expert panel dedicated to mapping the future of IV robotics was convened to determine barriers to widespread adoption of IV robotics in health systems and offer potential solutions to remove these barriers. The expert panel targeted 3 specific audiences: robot manufacturers, drug manufacturers, and fellow pharmacy leaders.
Conclusion: It is the hope of the international faculty that the information that emerged from the summit can be used by others to successfully implement IV compounding robotics in their sterile products areas to maximize patient safety. The summit also served as a call to action for pharmacy leaders, drug manufacturers, and robotic companies to develop a safer, more efficient future for patients by working together to optimize the development and operation of IV robotics.
(© American Society of Health-System Pharmacists 2021. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje